The vaccine showed better reactogenicity and safety outcomes, and enhanced humoral and cell-mediated immune responses compared with the Phase-1 trial Covaxin, India’s indigenous COVID-19 vaccine, showed enhanced immune response as …
Tag:
Phase2
-
-
Hyderabad: Prominent drug firm Bharat Biotech has submitted the phase-2 study results of Covaxin in 380 participants and stated that the vaccine against Covid-19 has accelerated the response from immune …
